{"id":"W2588916936","doi":"10.1182/blood.v128.22.792.792","title":"Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Imatinib; Clinical endpoint; Imatinib mesylate; Interim analysis; Myeloid leukemia; Gastroenterology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002794795,0.001006359,0.00261588,0.001185372,0.000377206,0.001143084,0.0006189361,0.0008868234,0.002118086],"category_scores_gemma":[0.00406043,0.0004149109,0.009279606,0.00111947,0.0003667673,0.0006867841,0.0008479021,0.0009939336,0.0002169284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004800746,"about_ca_system_score_gemma":0.0006324388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001854452,"about_ca_topic_score_gemma":0.003976793,"domain_scores_codex":[0.9972594,0.0008926284,0.0005450947,0.0006728011,0.000310745,0.000319277],"domain_scores_gemma":[0.9982195,0.0007694297,0.0004415564,0.0002800975,0.0001055721,0.0001837762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1854343,0.0006665185,0.6992896,0.001590415,0.07791808,0.0008482625,0.0005617997,0.001292354,0.005162755,0.000319781,0.002468821,0.02444724],"study_design_scores_gemma":[0.02361199,0.01001688,0.89312,0.000349174,0.05941321,0.001145151,0.00138953,0.004062304,0.001183773,0.001214867,0.004314607,0.0001784967],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917679,0.005151722,0.000439,0.0001473525,0.0001013872,0.0002679152,0.001544241,0.00001294674,0.0005675507],"genre_scores_gemma":[0.9969543,0.000463759,0.0002062668,0.0001612919,0.00009346976,0.0002161433,0.001635633,0.00001166019,0.0002575939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002794795,"threshold_uncertainty_score":0.01478052,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.013697153198881,"score_gpt":0.2777121560676303,"score_spread":0.2640150028687493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}